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ABSTRACT
Objectives: Acute chest pain (ACP) is a leading cause
of hospital emergency unit consultation. As there are
various underlying conditions, ranging from
musculoskeletal disorders to acute coronary syndrome
(ACS), thorough clinical diagnostics are warranted. The
aim of this prospective study was to assess whether
reproducible chest wall tenderness (CWT) on palpation
in patients with ACP can help to rule out ACS.
Methods: In this prospective, double-blinded
diagnostic study, all consecutive patients assessed in
the emergency unit at the University Hospital Zurich
because of ACP between July 2012 and December 2013
were included when a member of the study team was
present. Reproducible CWT on palpation was the initial
step and was recorded before further examinations were
initiated. The final diagnosis was adjudicated by a study-
independent physician.
Results: 121 patients (60.3% male, median age
47 years, IQR 34–66.5 years) were included. The
prevalence of ACS was 11.6%. Non-reproducible CWT
had a high sensitivity of 92.9% (95% CI 66.1% to
98.8%) for ACS and the presence of reproducible CWT
ruled out ACS (p=0.003) with a high negative predictive
value (98.1%, 95% CI 89.9% to 99.7%). Conversely
non-reproducible CWT ruled in ACS with low specificity
(48.6%, 95% CI 38.8% to 58.5%) and low positive
predictive value (19.1%, 95% CI 10.6% to 30.5%).
Conclusions: This prospective diagnostic study
supports the concept that reproducible CWT helps to
rule out ACS in patients with ACP in an early stage of
the evaluation process. However, ACS and other
diagnoses should be considered in patients with a
negative CWT test.
Trial registration number: ClinicalTrial.gov:
NCT01724996.
INTRODUCTION
Acute chest pain (ACP) accounts for approxi-
mately up to 10% of all medical emergency
room admissions.1–7 The estimated life time
prevalence of ACP in the general population
is 20–40%.8 The spectrum of underlying con-
ditions is broad and ranges from harmless
musculoskeletal causes, gastro-oesophageal
reﬂux disease, pneumonia, psychosomatic
disorders to life-threatening conditions like
pulmonary embolism, pneumothorax, aortic
dissection and acute coronary syndrome
(ACS). The reported incidence of ACS or
angina pectoris in patients with ACP ranges
between 4.8% and 12% in those seeking
their general practitioners,9–12 compared
with up to 24% in patients presenting to
University Hospital emergency units.10
In the diagnostic work-up of ACP, the
medical history, clinical examination, labora-
tory tests, ECG and radiographic imaging are
crucial to rapidly identify potentially life-
threatening conditions such as ACS.13–16 For
example, ECG has a reported sensitivity
between 20% and 60% for the diagnosis of
ACS.17 Laboratory results indicating myocardial
ischaemia (troponin-I, troponin-T creatine
kinase) may not be conclusive in the ﬁrst hours
after initiation of pain. This, therefore, man-
dates time-consuming serial laboratory tests.17
Patients at low-to-intermediate risk with nega-
tive troponin, and normal or unclear ECG
might have to undergo further testing like non-
invasive cardiac imaging with radiation expos-
ure.18 19 Such patients show more downstream
testing like expensive invasive coronary
Strengths and limitations of this study
▪ This is the first study to our knowledge with a
prospective, double-blinded design for the evalu-
ation of chest wall tenderness on palpation in
acute chest pain patients for ruling out acute cor-
onary syndrome.
▪ Our study supports data from previous studies
that reproducible chest wall tenderness helps to
rule out acute coronary syndrome in acute chest
pain admissions.
▪ Among the limitations are the small sample size
and the possible interobserver and intraoberser-
ver variability due to multiple study members
and difficulty of standardising the index test.
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angiography with additional radiation exposure and use of
nephrotoxic radiographic contrast medium.18 20 21
Hence, it is desirable to have an early, fast and reliable
bedside test to rule out ACS in patients presenting with
ACP. Reproducible chest wall tenderness (CWT) on palpa-
tion of the thorax, where the maximum pain sensation is
referred, is generally considered to be associated with a
benign musculoskeletal cause and may help to rule out
ACS in absence of additional examinations (ECG, labora-
tory tests, radiographic testing). Most of these studies were
retrospective, in general practitioner settings, or the test
was not clearly deﬁned as one of the initial steps in the
ACP evaluation process.22–25 The exact diagnostic value of
this sign has never been investigated in prospective and
appropriately blinded clinical studies. To ﬁll this lack of
knowledge we aimed to evaluate, with a strict prospective
and blinded design, the diagnostic performance of repro-
ducible CWT as an easy bedside test to rule out early sus-
pected ACS in emergency admissions presenting with ACP.
METHODS
Participants
Between July 2012 and December 2013, all consecutive
patients referred by a third party or self-referred patients
≥18 years presenting with self-reported ACP (ﬁrst or recur-
rent episode) at the emergency unit of the University
Hospital Zurich were prospectively included in this study
when a member of the study team was present. Exclusion
criteria were recent thoracic surgery within 1 year, any
chronic inﬂammatory joint or connective tissue disease,
ﬁbromyalgia and unstable haemodynamic condition with
systolic blood pressure ≤90 mmHg or tachyarrhythmia.
Furthermore, patients referred directly to the cardiac
chest pain unit by a third party or for whom laboratory
results, ECG or chest X-ray were already available at the
time of enrolment were excluded.
Written informed consent was obtained from all
patients. The study was registered at http://www.
clinicaltrials.gov (NCT01724996).
Index test
The index test is reproducible CWT on palpation.
Patients were brought into supine position with 30° ele-
vated upper body. Flat digital index with moderate pres-
sure was applied, where the maximum pain was pointed
by the patient. ‘Reproducible CWT’ or ‘non-reproducible
CWT’ was noted.
Presence of reproducible CWTwas deﬁned as the follow-
ing: the self-reported pain could be provoked in the same
quality and intensity by digital palpation over the region of
complaints over the chest. If no pain or any other pain
than the self-reported pain by palpation could be elicited,
the test result was deﬁned as non-reproducible CWT.
Reference test
ACS was deﬁned according to the universal deﬁnition of
acute myocardial infarction in the ESC Guidelines from
2012.26The gold standard reference tests to rule out ACS
in patients with ACP are serial troponin measurements
and/or ECG.27
Study course in the emergency unit
After admission to the emergency unit, the ﬁrst assess-
ment and triage of patients with ACP was conducted by
an attending physician or nurse not related to the study
team to check for haemodynamic stability and for the
need of urgent medical care. After enrolment, an inves-
tigator of the study performed the index test. Index test
of CWT was noted before completing the standardised
questionnaire (see below), and further initial routine
clinical diagnostics, including medical history, physical
examination, ECG, laboratory testing and chest X-ray,
were initiated by a study-independent emergency phys-
ician. At the time of chest palpation, the investigator
was blinded for the ﬁnal diagnosis, which was made by
another emergency physician independent of the study
team, based on the initial diagnostic work-up and
possible further examinations (eg, coronary angiog-
raphy, CT).
Questionnaire and data collection
Intensity of ACP was graded with the visual analogue
scale (VAS) ranging from 0 (no pain) to 10 (worst pain).
Localisation of maximum pain (retrosternal, left or right
chest side), pain radiation (right arm, left arm, neck,
back or epigastric), quality of pain (stabbing, pressure,
burning or squeezing), pain aggravating and relieving
factors (respiration, movements or rest), and additional
symptoms (dyspnoea, nausea, vertigo, sweating) were
asked. Moreover, it was noted whether ACP was a ﬁrst
episode or recurrent episode, and if the patient was self-
referred or referred by a third party. Previous coronary
artery disease (CAD), cardiovascular risk factors (arterial
hypertension, dyslipidaemia, obesity, family history, dia-
betes mellitus, smoking status), illicit drug use, alcohol
consumption, medication and demographic data were
registered.
Statistical analysis
All statistical analyses were performed using IBM SPSS
Statistics for Windows, V.22 (IBM Corporation, Armonk,
New York, USA). Data are reported as median±IQR from
25th to 75th centile or mean±SD or percentages, as appro-
priate. Continuous variables were analysed using the
Student t test or Mann-Whitney U test, as appropriate.
Categorical data were analysed with χ2 test or Fisher’s
exact test, respectively. p Values of all outcomes were two-
sided; a value less than 0.05 was considered to indicate stat-
istical signiﬁcance. CI was deﬁned as 95%. Furthermore,
diagnostic sensitivity, speciﬁcity, positive predictive value
(PPV), negative predictive value (NPV), likelihood ratio
(LR) and OR of reproducible CWT for ruling in or ruling
out ACS were analysed. Multivariable logistic regression
analysis was applied to investigate the independent associ-
ation between ACS and CWT, controlling for established
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cardiovascular risk factors (known CAD, age, sex, arterial
hypertension, dyslipidaemia, family history of CAD,
smoking and diabetes). Goodness-of-ﬁt of the model was
tested using Hosmer-Lemeshow χ2 test.
RESULTS
Participants
A total of 121 patients (median age 47 years, IQR 34–
66.5 years, 60.3% male) were included in the study. In
total, 71.1% of patients were self-referrals. In 52.9% of
patients, the ACP was the ﬁrst episode. Demographic
data and cardiovascular risk proﬁle of all emergency
admissions with ACP and categorised as ACS and
non-ACS are summarised in table 1. Patients in the ACS
group were signiﬁcantly older and cardiovascular risk
factors (dyslipidaemia and hypertension) were more
prevalent. In ﬁgure 1 the self-reported localisation of
the maximum ACP sensation is shown.
The characterisation of symptoms on emergency room
admission is displayed in table 2. The self-reported chest
pain in the ACS group was localised mainly retrosternal,
and described as pressure compared with patients
without ACS who had stabbing pain on the left side with
aggravation on deep inspiration.
Final diagnosis
The leading cause of ACP was a musculoskeletal disorder
(62, 51.2%) after other diagnoses had been excluded
(table 3). In 14 (11.6%) patients, of whom the large
majority were men, based on troponin and/or ECG
changes the ﬁnal diagnosis of ACS could be made.
Thirteen patients were treated with percutaneous coron-
ary intervention using drug-eluting stents while one
was referred for urgent coronary artery bypass surgery
(ﬁgure 2).
In ﬁgure 2 the ﬂow chart of enrolment and outcomes
of CWT test in ACP admissions is shown.
Table 1 Baseline characteristics of all emergency admissions with ACP
All emergency
admissions with ACP ACS Non-ACS p Value
N 121 14 (11.6%) 107 (88.4%)
Gender (male) 73 (60.3%) 10 (71.4%) 63 (58.87%) 0.56
Age [years] 47 [34–66.5] 61.0 [54.5–66.3] 45.0 [34.0–68] 0.011
BMI (kg/m2) 27.0 [24.4–29.7] 27.0 [25.7–30.0] 27.0 [23.9–29.6] 0.268
Systolic blood pressure [mm Hg] 132.5 [122.0–143.50] 144.5 [133.0–154.8] 130.5 [121.0–141.0] 0.014
Diastolic blood pressure [mm Hg] 81 [76.0–90] 90 [80.0–100.0] 80 [75.0–89.3] 0.031
Heart rate (*/min) 75 [66.0–88.0] 76 [63.8–85.0] 75 [66–88] 0.784
VAS (0–10) 5.0 [4.0–7.0] 5 [2.0–7.3] 5 [4–7] 1.0
Previous medication:
Antihypertensive medication 36 (29.8%) 6 (42.9%) 28 (28.0%) 0.35
Analgesic medication 25 (20.7%) 3 (21.4%) 22 (20.6%) 1.00
Anticoagulants 31 (25.6%) 6 (42.9%) 25 (23.4%) 0.19
Alcohol abuse 33 (27.5%) 8 (57.1%) 25 (23.4%) 0.021
Illicit drug abuse 8 (6.6%) 0 8 (7.5%) 0.59
Smoker 43 (35.5%) 5 (35.7%) 38 (35.5%) 1.0
Cigarettes consumption [PY] 7.21 (±14.9) 10.0 (±16.1) 6.9 (±14.8) 0.67
Hypertension 47 (38.8%) 11 (78.6%) 36 (33.6%) 0.002
Known CAD 18 (14.9%) 2 (14.3%) 16 (15.0%) 1.0
Dyslipidaemia 33 (27.3%) 8 (57.1%) 25 (23.4%) 0.021
Family history positive for CAD 37 (30.6%) 7 (50.0%) 30 (28.0%) 0.123
Diabetes mellitus 6 (5.0%) 0 6 (5.6%) 1.0
Bold typeface indicates significant results.
(±), SD; [], IQR; ACP, acute chest pain; ACS, acute coronary syndrome; BMI, body mass index; CAD, coronary artery disease; PY, pack
years; VAS, visual analogue scale.
Figure 1 Localisation and percentage distribution of
self-reported acute chest pain in all patients.
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Index test ‘CWT’ versus reference test ‘troponin and/or ECG’
versus ‘troponin’
Based on the reference test of troponin and/or ECG, 14
out of 121 were classiﬁed as patients with ACS.
Fifty-three of the 121 patients had reproducible CWT. In
13 of the 14 patients with ACS, CWT was non-
reproducible resulting in a sensitivity of 92.9%; 52 out of
107 patients without ACS had reproducible CWT result-
ing in a speciﬁcity of 48.6%. Only 1 out of 53 patients
with reproducible CWT suffered from ACS resulting in a
NPV of 98.1%. In contrast, 13 out of the 68 patients with
non-reproducible CWT suffered from ACS resulting in a
PPV of 19.1%. Serial troponin measurements showed a
sensitivity of 85.7% and speciﬁcity of 86.9%, PPV of
46.2% and NPV for 97.9% for ACS (tables 4 and 5) com-
pared with the reference test of troponin and/or ECG.
Non-reproducible CWT remained independently asso-
ciated with ACS after correction for known CAD, age,
gender, family history of CAD, arterial hypertension,
smoking, diabetes and dyslipidaemia resulting in an
adjusted OR of 7.5 (95% CI 1.4 to 40.1; p=0.018). The
model showed no evidence of lack of ﬁt based on the
Hosmer-Lemeshow χ2 statistic.
DISCUSSION
Clinical examination, including palpation of the chest
wall, is part of the routine evaluation of patients with ACP.
Reproducible CWT in patients presenting with ACP may
be associated with a benign cause like musculoskeletal dis-
orders and may help to rule out ACS.22 23 In our prospect-
ive study in the emergency department of the University
Hospital Zurich, we evaluated the diagnostic performance
of CWT on palpation to rule out ACS in patients present-
ing with ACP. Non-reproducible CWT had a high sensitiv-
ity, low speciﬁcity and low PPV for the diagnosis of ACS.
However, the presence of reproducible CWT helped to
rule out ACS with a high NPV. The results of this prospect-
ive, double-blinded study are consistent with other ﬁnd-
ings in retrospective analyses with different patient cohorts
and settings. A recent cross-sectional study carried out by
general physicians showed that reproducible CWT in
patients presenting with chest pain had an adjusted OR in
a multivariate model of 0.27 for the diagnosis of CAD.
Corresponding positive LR and negative LR for the pres-
ence of CWT for excluding and including CAD were 0.25
and 1.71, respectively.8 According to meta-analysis data,
reproducible CWT had, compared with our study, a
similar sensitivity (3–15%) and speciﬁcity (64–83%) for
the diagnosis of ACS. In reproducible CWT, positive LR
was 0.3, and in non-reproducible CWT, negative LR
increases to 1.3 suggesting that reproducible CWT is nega-
tively associated with ACS.24 Similar results were published
in the meta-analysis by Bruyninckx et al who reported a
94% sensitivity of non-reproducible CWT for the diagnosis
of ACS. Negative LR in the setting of non-reproducible
CWT was 0.17.25 In another cross-sectional study, a predic-
tion score in patients with ACP and underlying possible
Table 2 Characterisation of symptoms on emergency
room admission
ACS
(n=14)
Non-ACS
(n=107) p Value
Pain localisation
Retrosternal 11 (78.6%) 33 (30.8%) <0.001
Left chest 3 (21.4%) 65 (60.8%) 0.008
Right chest 0 8 (7.5%) 0.59
Epigastric 0 1 (0.9%) 1.0
Pain character
Stabbing 3 (21.4%) 61 (57.0%) 0.02
Pressure 9 (64.3%) 33 (30.8%) 0.01
Burning 2 (14.3%) 6 (5.6%) 0.23
Squeezing 0 7 (6.5%) 1.0
Pain radiation
No radiation 4 (28.6%) 52 (48.6%) 0.25
Left arm 5 (35.7%) 24 (22.4%) 0.31
Right arm 3 (21.4%) 9 (8.4%) 0.14
Jaw 1 (7.1%) 5 (4.7%) 0.52
Back 1 (7.1%) 13 (12.1%) 1.0
Epigastric 0 4 (3.7%) 1.0
Pain alleviating factors
No 9 (64.3%) 51 (49.0%) 0.24
Respiration 0 3 (2.9%) 1.0
Movement 0 7 (6.7%) 1.0
Rest 5 (35.7%) 46 (44.2%) 0.78
Pain aggravating factors
No 6 (42.9%) 40 (37.37%) 0.77
Respiration 1 (7.1%) 41 (38.38%) 0.03
Movement 6 (42.9%) 25 (23.23%) 0.19
Rest 1 (7.1%) 1 (1.01%) 0.22
Additional symptoms
No 6 (42.9%) 60 (57.7%) 0.40
Dyspnoea 5 (35.7%) 24 (23.1%) 0.32
Nausea 0 7 (6.7%) 1.0
Dizziness 2 (14.2%) 9 (8.7%) 0.61
Sweating 1 (7.1%) 7 (6.7%) 1.0
ACS, acute coronary syndrome.
Table 3 Final diagnosis after emergency unit admission
with acute chest pain
Diagnosis Total (N=121)
Musculoskeletal disorder 62 (51.2%)
Acute coronary syndrome 14 (11.6%)
Gastro-oesophageal reflux disease 6 (5.0%)
Pneumonia 6 (5.0%)
Tachyarrhythmia 7 (5.8%)
Perimyocarditis 6 (5.0%)
Pulmonary embolism 5 (4.1%)
Stable angina pectoris 5 (4.1%)
Pleuritis 3 (2.5%)
Hypertensive emergency 3 (2.5%)
Psychosomatic disorder 3 (2.5%)
Aortic dissection 1 (0.8%)
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CAD was proposed for general practitioners. Aside from
other ﬁve variables (age, gender, known vascular disease,
‘patient thinks heart is causing the pain’, exercise-
dependent pain), ‘pain not reproducible on palpation’
was an independent determinant for the prediction of a
CAD. Non-reproducible CWT on palpation had an
adjusted OR of 3.15.28 In our study sample, we could
detect reproducible CWT as an independent determinant
to rule out ACS after correction for the established
Figure 2 Enrolment and
outcomes of ACP admissions and
CWT test. ACP, acute chest pain;
ACS, acute coronary syndrome;
CWT, chest wall tenderness.
Table 4 Reproducible chest wall tenderness in patients
with and without ACS
ACS
(n=14)
Non-ACS
(n=107) p Value
Non-reproducible
CWT
13 (92.8%) 55 (51.4%) 0.003
Reproducible CWT 1 (7.1%) 52 (48.6%)
ACS, acute coronary syndrome; CWT, chest wall tenderness.
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cardiovascular risk factors in a multivariate model with an
OR of 7.5, which is consistent with the data from Chun
and McGee.24 Our study results also conﬁrm the data ana-
lysed by Goodacre et al17 who stated that non-reproducible
CWT had a sensitivity of 91.7%, low speciﬁcity of 27.8%,
PPV of 4.2%, NPV of 99.0%, positive LR of 1.27 and nega-
tive LR of 0.30 for the diagnosis of ACS. However, in most
of the publications, the quality of CWT was not clearly
deﬁned. Furthermore, the sequence of the clinical evalu-
ation was not clearly deﬁned and it is not evident if the
investigator or patient was already informed about further
test results or differential diagnoses.22–25 To address these
issues, we designed our study as strictly prospective enab-
ling the blinding of patient and investigator for the
primary end point. We conducted CWT as an initial step
showing that reproducible CWT as a fast bedside test
helped to rule out ACS in a very early stage. Moreover, we
only considered reproducible CWT (ie, pain triggered by
palpation corresponds exactly to the self-reported ACP).
CWT of alternative quality was excluded and registered as
non-reproducible CWT. The important new ﬁnding of our
study is that only reproducible CWT helps to rule out ACS
and not any CWT. Interestingly our index test ‘non-repro-
ducible CWT’ had a similar sensitivity and NPV compared
with the reference test of serial troponin measurements
for ruling out ACS in ACP. However, serial troponin ana-
lysis is time consuming compared with the fast and easy
CWT test. Nevertheless, troponin is highly speciﬁc, thus
resulting in better PPV for the diagnosis of ACS.29
Regarding the secondary end points, ACP in ACS group
was mainly reported retrosternal, pressure-like and less
stabbing like that which is consistent with previous
studies.23 30 Deep inspiration as pain aggravating factor
was signiﬁcantly more reported in the non-ACS group,
most probably due to underlying musculoskeletal disorder,
pleuritis or perimyocarditis.
LIMITATIONS
Albeit the members of the study team were blinded for
the ﬁnal diagnosis, the physical appearance of the
patients (eg, body mass index, gender, age) could have
biased the physician. Furthermore, the applied pressure
for testing of CWT is not standardised, which may
have led to interobserver and intraobserver variability.
Using a dolorimeter31 could help to minimise this bias.
However, the aim of the study was to investigate a simple
bedside test and a dolorimeter is not applicable in daily
clinical practice. Another limitation was that patient
enrolment was only carried out when a member of the
study team was present. Also of note is that the ACS
group in our study population was too small to evaluate
other predictive factors for the diagnosis of ACS, includ-
ing aspects of the patient’s history and pain character-
istics in multivariate analysis. The subgroup analysis
considering age, gender, socioeconomic status, pre-
existing conditions would also require a greater sample
size. Nevertheless, a subgroup analysis concerning the
impact of these factors on CWT would be of great inter-
est as there is evidence for differences in pain percep-
tion in different age groups, gender, socioeconomic
status and in patients with comorbidities.32–34 These sub-
group studies might have implications for clinicians in
dealing with patients presenting with ACP.
CONCLUSION
This ﬁrst prospective, double-blinded diagnostic study
shows that palpation of the chest wall is a fast and easy
feasible bedside test in patients presenting with ACP. If
reproducible CWT is present, the test helps to rule out
ACS at an early stage of the diagnostic process. However,
ACS or other diagnoses should be considered in patients
with non-reproducible CWT. It goes without saying that
testing of CWT does not replace a thorough history
taking, and clinical and further diagnostic evaluation.
However, this study demonstrates that palpation of the
chest wall should be performed as a ﬁrst step in ACP
admissions to improve early triage and decision-making
until ECG and troponin tests are available. Larger
studies are needed to conﬁrm these ﬁndings.
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Table 5 Diagnostic performance of ‘non-reproducible CWT’ and ‘troponin’ for the diagnosis of acute coronary syndrome
Non-reproducible CWT Serial troponin
95% CI p Value 95% CI p Value
Sensitivity 92.9% 66.1% to 98.8% 0.003 85.7% 57.2 to 97.8% 0.000
Specificity 48.6% 38.8% to 58.5% 86.9% 79.0% to 92.65%
PPV 19.1% 10.6% to 30.5% 46.2% 26.61% to 66.1%
NPV 98.1% 89.9% to 99.7% 97.9% 92.6% to 99.7%
Positive LR 1.8 1.4 to 2.3 6.6 3.8 to 11.2
Negative LR 0.15 0.02 to 2.3 0.16 0.05 to 0.6
OR 1.6 to 97.3 0.017 39.9 8.1 to 197.2 0.000
CWT, chest wall tenderness; LR, likelihood ratio; NPV, negative predictive value; PPV, positive predictive value.
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